Name: Latest research reports of Solara Active Pharma Sciences Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Solara Active Pharma Sciences Ltd.
Rating: 5
Author: Axis Direct

Solara Active Pharma Sciences Ltd.

NSE: SOLARA | BSE: 541540 | ISIN: INE624Z01016 | Industry: Pharmaceuticals
| Mid-range Performer

575.6000 12.50 (2.22%)

NSE Jan 02, 2026 10:29 AM

29.99% Gain from 52W Low

Volume: 18,056

Solara Active Pharma Sciences Ltd.

04 Feb 2021

575.60

2.22%

Result Update:Solara Active

Buy: Solara Active Pharma Scien...

Target

Axis Direct

Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.

Promoters unpledged 3.63% of shares in last quarter. Total pledge stands at 35.32% of promoter holdings